(Press-News.org)
Dr. James McCully of Harvard Medical School and Boston Children's Hospital, USA, invited by Dr. Marvin Edeas, from Institut Cochin, Université Paris Cité, France, will host an instructive discussion on Mitochondrial Transplantation.
This collaboration with the World Mitochondria Society (WMS) promises an insightful presentation by Dr. McCully on the topic of "Mitochondrial Transplantation: Rescue of Cellular Viability and Function and Modulation of the Ischemic Phenotype in the Myocardium." Dr. McCully will present the role of mitochondrial transplantation in enhancing outcomes for myocardial ischemia/reperfusion injury and its profound impact on the transcriptomic profile.
Marvin Edeas, chairman and founder of the WMS, Université Paris Cité, stated: “We invited Dr. James McCully as he plays a strategic role in the field of medicine, especially his groundbreaking work in pediatric cardiac surgery and his development of mitochondrial transplantation. Dr. McCully has dedicated his career to innovating treatment approaches for congenital heart conditions, significantly improving outcomes for pediatric patients. His research has not only advanced surgical procedures but also introduced new technologies to enhance the quality of life for children with heart defects.
The technique of mitochondrial transplantation, pioneered by Dr. McCully, represents a major advancement in medical science, offering a novel method to deliver healthy mitochondria directly to damaged tissues, thus rescuing organ function. This innovation, first applied at Boston Children's Hospital in 2014, has shown that mitochondrial transplantation can safely and effectively restore injured heart muscle, even in critical cases.
Given Dr. McCully's extensive publication record, with 234 papers and 13 patents, and his involvement in leading scientific associations, his expertise and contributions are highly valued by the medical community. His work aligns closely with the interests of the World Mitochondria Society, making him an ideal candidate to share insights on the therapeutic efficacy of mitochondrial transplantation in treating myocardial ischemia/reperfusion injury and its potential for broader applications in medicine.”
Date & Venue
The webinar is scheduled for Friday, March 22, 2024, from 3:00 PM to 5:15 PM Paris time.
Participants can choose to attend the event in two ways:
In person at the Université Paris Cité, Institut Cochin - Bâtiment Méchain, Salle Rosalind Franklin, in Paris.
Virtually, through a Zoom webinar.
Registration & Participation
Attendance at this webinar is free of charge, but space is limited. We encourage interested individuals to register early to secure their participation.
Registration link: https://cdn.jotfor.ms/240723340827453. The Zoom link will be sent after registration.
Mitochondrial Transplantation will be highlighted during WMS Annual Meeting
As an active member of the World Mitochondria Society’s scientific board, Dr. McCully 2024, he will be chairing a session during the Annual Targeting Mitochondria 2024 Congress “Mitochondrial Medicine 2024: From Bench to Bedside,” where mitochondrial transplantation will be prominently discussed.
About World Mitochondria Society
The World Mitochondria Society, established in 2010, is dedicated to addressing the evolving challenges in mitochondrial research with a forward-thinking agenda. Under the leadership of President Volkmar Weissig and Founder Marvin Edeas, we prioritize Emerging Trends and Strategies to stimulate innovative discussions and explore new avenues in mitochondrial science.
Where to Find WMS?
LinkedIn Page
Facebook Page
Eurekalert Releases
Subscribe to our Newsletter.
END
Winston-Salem, North Carolina – March 18, 2024 – The Regenerative Manufacturing Innovation Consortium (RegMIC), a leading organization focused on advancing the field of regenerative medicine, today announced its annual meeting, scheduled for May 15, 2024, at the DoubleTree by Hilton Charlotte Airport. RegMIC is an initiative from the Regenerative Medicine Development Organization (ReMDO).
This year’s meeting will convene industry leaders, researchers, and innovators to explore the latest advancements and opportunities in regenerative ...
U.S. Energy Secretary Jennifer Granholm appointed Joe Powell, the founding executive director of the Energy Transition Institute at the University of Houston, to the U.S. Department of Energy’s Industrial Technology Innovation Advisory Committee (ITIAC).
The 18-member committee, a diverse group of stakeholders who report directly to Granholm, will create a comprehensive strategy to accelerate the development of innovative technologies and processes designed to help decarbonize the American industrial sector and reduce emissions. This sector is ...
One of the largest studies on wildlife activity—involving more than 220 researchers, 163 mammal species and 5,000 camera traps worldwide—reveals that wild animals react differently to humans depending on where the animals live and what they eat.
Bigger herbivores—plant-eating animals like deer or moose—tend to become more active when humans are around, while meat-eaters like wolves or wolverines tend to be less active, preferring to avoid risky encounters.
Urban animals like deer or raccoons may become more active around people, as they get used to human presence and find food like garbage or plants, which they can access at night. But ...
The Organoid group at the Hubrecht Institute have identified a new link between FBXW7 mutations and EGFR signaling activity. The FBXW7 gene is commonly mutated in colorectal cancer and such mutations have been associated with worse treatment outcome. The researchers used colon organoids and the CRISPR/Cas9 gene editing technique to investigate the consequences of multiple common FBXW7 mutations. Further understanding of the link with EGFR signaling could help improve treatment strategies for colorectal cancer. The research was published on March 14th in Proceedings of the national academies of sciences (PNAS).
Cancer is caused by the accumulation of mutations in different ...
The use of antipsychotics during pregnancy isn’t linked to childhood neurodevelopmental disorders or learning difficulties, UNSW Sydney-led study shows – giving assurance to those concerned about continuing their medications during pregnancy.
Antipsychotics – a branch of medication designed to treat schizophrenia and bipolar disorder – are important tools for mental health care management. They work by blocking the effect of dopamine, which can help reduce psychotic symptoms such as hallucinations or delusions.
These versatile ...
For younger Black patients living in rural parts of the Southeastern United States, peer coaching is more effective than traditional clinical care in controlling high blood pressure, according to a new study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian. The investigators learned that for people under age 60 who have persistently uncontrolled hypertension, the benefits of working with a peer health coach were equivalent to what would be expected from taking a low dose of blood pressure medication.
The findings were published March 18 in JAMA Internal Medicine. The randomized ...
About The Study: The findings of this study indicate that childhood lead exposure from drinking water is widespread in Chicago, and racial inequities are present in both testing rates and exposure levels. Machine learning may assist in preliminary screening for lead exposure, and efforts to remediate the effects of environmental racism should involve improving outreach for and access to lead testing services.
Authors: Benjamin Q. Huynh, Ph.D., of the Johns Hopkins University Bloomberg School of Public Health in Baltimore, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamapediatrics.2024.0133)
Editor’s ...
Mothers and daughters have a strong bond, yet do you know that connections reminiscent of this close relationship extend all the way to the cellular level? During the process of cell division, new daughter cells inherit a mix of genetic material and other molecules from their mother cells. This inheritance includes both beneficial components, which can help them for a robust start in life, and potentially harmful mutations or damaged molecules, posing significant challenges for the newly born daughter cells. How daughter cells manage and ...
Embargoed press materials are now available for Discover BMB, the annual meeting of the American Society for Biochemistry and Molecular Biology. Top scientists and educators in the field will gather at the meeting, March 23–26 in San Antonio.
Reporters are invited to attend an exciting lineup of in-person scientific sessions in San Antonio or access press materials electronically. Register now or find more information in the #DiscoverBMB newsroom. Please note that only a limited number of complementary on-site press passes will be issued, so advance registration is recommended.
Explore the schedule at a ...
Researchers at the Weizmann Institute of Science in Israel have identified a yeast that could be used to prevent invasive candidiasis, a major cause of death in hospitalized and immunocompromised patients. The study, to be published March 18 in the Journal of Experimental Medicine (JEM), shows that the novel yeast lives harmlessly in the intestines of mice and humans and can displace the yeast responsible for candidiasis, Candida albicans.
Millions of microbial species live within or on the human body, many of them being harmless or even beneficial to human health. The microscopic yeast C. albicans is commonly found in the intestines ...
